Cargando…
Early detection of recurrence by (18)FDG-PET in the follow-up of patients with colorectal cancer
We assessed the potential benefits of including systematic (18)fluorodeoxyglucose positron emission tomography (FDG-PET) for detecting tumour recurrence in a prospective randomised trial. Patients (N=130) who had undergone curative therapy were randomised to undergo either conventional (Con) or FDG-...
Autores principales: | Sobhani, I, Tiret, E, Lebtahi, R, Aparicio, T, Itti, E, Montravers, F, Vaylet, C, Rougier, P, André, T, Gornet, J M, Cherqui, D, Delbaldo, C, Panis, Y, Talbot, J N, Meignan, M, Le Guludec, D |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2266857/ https://www.ncbi.nlm.nih.gov/pubmed/18301402 http://dx.doi.org/10.1038/sj.bjc.6604263 |
Ejemplares similares
-
FDG-PET in lymphoma
por: Meignan, Michel
Publicado: (2014) -
Colorectal cancer (CRC) monitoring by 6-monthly (18)FDG-PET/CT: an open-label multicentre randomised trial
por: Sobhani, I, et al.
Publicado: (2018) -
[(18)F]FDG PET/CT predicts progression-free survival in patients with idiopathic pulmonary fibrosis
por: Justet, Aurélien, et al.
Publicado: (2017) -
Cerebral (18)F-FDG PET in macrophagic myofasciitis: An individual SVM-based approach
por: Blanc-Durand, Paul, et al.
Publicado: (2017) -
Interference of Known or Suspected Endometriosis in Reporting FDG PET/CT Performed in Another Indication
por: Balogova, Sona, et al.
Publicado: (2022)